Text Size

Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2006 by E-DA Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
E-DA Hospital
ClinicalTrials.gov Identifier:
NCT00395616
First received: November 2, 2006
Last updated: NA
Last verified: November 2006
History: No changes posted
  Purpose

Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.


Condition Intervention
Type A Botulinum Toxin
Tennis Elbow
 Drug: Botox (drug)

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by E-DA Hospital:

Primary Outcome Measures:
  • WHOQOL-BREF
  • visual analogue scale for pain
  • grip strength

Estimated Enrollment: 40
Study Start Date: November 2006
  Eligibility

Ages Eligible for Study:   20 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pain at the lateral epicondyle of the elbow
  • Tenderness at the lateral epicondyle of the elbow
  • Pain on resisted extension of the wrist

Exclusion Criteria:

  • Local injection of steroid within 3 months
  • Previous elbow trauma or operations
  • Pregnancy
  • Systemic neuromuscular disorders such as myasthenia gravis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00395616

Contacts
Contact: Yu-Ching Lin, MD 886-7-6150011 ext 2367 yuchinglin2003@yahoo.com.tw

Locations
Taiwan
E-Dah Hospital Recruiting
Kaohsiung,, Taiwan, 833
Contact: Yu-Ching Lin, MD     886-7-6150011 ext 2367     yuchinglin2003@yahoo.com.tw    
Sponsors and Collaborators
E-DA Hospital
Investigators
Study Chair: Yu-Ching Lin, MD E-Dah Hospital, Kaohsiung, Taiwan
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00395616     History of Changes
Other Study ID Numbers: e120537192
Study First Received: November 2, 2006
Last Updated: November 2, 2006
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Tennis Elbow
Musculoskeletal Diseases
Arm Injuries
Wounds and Injuries
Botulinum Toxins
 Anti-Dyskinesia Agents
Central Nervous System Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 23, 2013